Identifying patients at risk of neutropenic sepsis
A&S Science Previous     Next

Identifying patients at risk of neutropenic sepsis

Sameena Khan Foundation year two doctor, Christie NHS Foundation Trust, Manchester
Andrew McPartlin Specialist registrar, clinical oncology, Christie NHS Foundation Trust, Manchester
Christine Tetlow Clinical audit facilitator, Christie NHS Foundation Trust, Manchester
Ananya Choudhury Consultant and honorary clinical lecturer, Clinical oncology, at the Christie NHS Foundation Trust, Manchester
Jeanette Lyons Nurse clinician, clinical oncology, Christie NHS Foundation Trust, Manchester

Sameena Khan and colleagues report on an initiative to ensure timely treatment of patients undergoing chemotherapy for urothelial malignancies who are at risk of developing infection

An audit of mortality figures for patients undergoing chemotherapy for urothelial malignancies identified three deaths as a result of neutropenic sepsis in the authors’ centre. Before the introduction of the initiative described in this article, midstream specimen of urine samples were taken and sent for analysis for every patient. The development of a protocol to identify at-risk patients aims to ensure timely prescription of antibiotics and avoid admissions for neutropenic sepsis.

Cancer Nursing Practice. 11, 6,16-21. doi: 10.7748/cnp2012.07.11.6.16.c9200

Correspondence

Jeanette.lyons@christie.nhs.uk

Peer review

This article has been subject to double blind peer review

Conflict of interest

None declared

You need a subscription to read the full article